5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate has been researched along with Brain Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gennarelli, TA; Leach, M; McIntosh, TK; Okiyama, K; Simon, RP; Smith, DH | 1 |
1 other study(ies) available for 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and Brain Injuries
| Article | Year |
|---|---|
The sodium channel blocker and glutamate release inhibitor BW1003C87 and magnesium attenuate regional cerebral edema following experimental brain injury in the rat.
Topics: Animals; Brain Edema; Brain Injuries; Excitatory Amino Acid Antagonists; Magnesium Chloride; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers | 1995 |